Marcus Michels

Marcus Michels

Auto-generated profile, based on publicly available information

Marcus Michels

Universidade Federal do Rio Grande do Sul (UFRGS), Brasil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Neuroscience Letters
Verified
Journal Article
Closed access
VBVictorio Bambini-Junior
Victorio Bambini-Junior
Geancarlo ZanattaGeancarlo Zanatta
Geancarlo Zanatta
Gustavo Della-Flora NunesGustavo Della-Flora Nunes
Gustavo Della-Flora Nunes
GMGabriela Mueller de Melo
Gabriela Mueller de Melo
MMMarcus Michels
Marcus Michels
CGCarmem Gottfried
Carmem Gottfried

1 July 2013 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
LCLuciane Costa-Campos
Luciane Costa-Campos
AHAna P. Herrmann
Ana P. Herrmann
LPLuisa K. Pilz
Luisa K. Pilz
MMMarcus Michels
Marcus Michels
GNGuilherme Noetzold
Guilherme Noetzold
EEElaine Elisabetsky
Elaine Elisabetsky

28 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BSBianca Marmontel de Souza
Bianca Marmontel de Souza
MMMarcus Michels
Marcus Michels
DSDenise Alves Sortica
Denise Alves Sortica
ABAna Paula Bouças
Ana Paula Bouças
JRJakeline Rheinheimer
Jakeline Rheinheimer
DCDaisy Crispim
Daisy Crispim
Uncoupling protein 2 (UCP2) reduces production of reactive oxygen species (ROS) by mitochondria. ROS overproduction is one of the major contributors to the pathogenesis of chronic diabetic complications, such as diabetic kidney disease (DKD). Thus, deleterious polymorphisms in the UCP2 gene are candidate risk factors for DKD. In this study, we investigated whether UCP2 -866G/A, Ala55Val and Ins/Del polymorphisms were associated with DKD in patients with type 2 diabetes mellitus (T2DM), and whether they had an effect on UCP2 gene expression in human kidney tissue biopsies. In a case-control study, frequencies of the UCP2 -866G/A, Ala55Val and Ins/Del polymorphisms as well as frequencies of the haplotypes constituted by them were analyzed in 287 T2DM patients with DKD and 281 T2DM patients without this complication. In a cross-sectional study, UCP2 gene expression was evaluated in 42 kidney biopsy samples stratified according to the presence of the UCP2 mutated -866A/55Val/Ins haplotype. In the T2DM group, multivariate logistic regression analysis showed that the -866A/55Val/Ins haplotype was an independent risk factor for DKD (OR = 2.136, 95% CI 1.036–4.404), although neither genotype nor allele frequencies of the individual polymorphisms differed between case and control groups. Interestingly, T2DM patients carrying the mutated haplotype showed decreased estimated glomerular filtration rate (eGFR) when compared to subjects with the reference haplotype (adjusted P= 0.035). In kidney biopsy samples, UCP2 expression was significantly decreased in UCP2 mutated haplotype carriers when compared to kidneys from patients with the reference haplotype (0.32 ± 1.20 vs. 1.85 ± 1.16 n fold change; adjusted P< 0.000001). Data reported here suggest that the UCP2 -866A/55Val/Ins haplotype is associated with an increased risk for DKD and with a lower eGFR in T2DM patients. Furthermore, this mutated haplotype was associated with decreased UCP2 gene expression in human kidneys.

1 September 2019 in Genetics and Molecular Biology
Verified
Journal Article
Open access
MMMarcus Michels
Marcus Michels
UMUrsula Matte
Ursula Matte
LFLucas Rosa Fraga
Lucas Rosa Fraga
AMAline Castello Branco Mancuso
Aline Castello Branco Mancuso
RLRodrigo Ligabue-Braun
Rodrigo Ligabue-Braun
MSMaria Teresa Vieira Sanseverino
Maria Teresa Vieira Sanseverino
Pathogenic variants in the Cystic Fibrosis Transmembrane Conductance Regulator gene (CFTR) are responsible for cystic fibrosis (CF), the commonest monogenic autosomal recessive disease, and CFTR-related disorders in infants and youth. Diagnosis of such diseases relies on clinical, functional, and molecular studies. To date, over 2,000 variants have been described on CFTR (~40% missense). Since few of them have confirmed pathogenicity, in silico analysis could help molecular diagnosis and genetic counseling. Here, the pathogenicity of 779 CFTR missense variants was predicted by consensus predictor PredictSNP and compared to annotations on CFTR2 and ClinVar. Sensitivity and specificity analysis was divided into modeling and validation phases using just variants annotated on CFTR2 and/or ClinVar that were not in the validation datasets of the analyzed predictors. After validation phase, MAPP and PhDSNP achieved maximum specificity but low sensitivity. Otherwise, SNAP had maximum sensitivity but null specificity. PredictSNP, PolyPhen-1, PolyPhen-2, SIFT, nsSNPAnalyzer had either low sensitivity or specificity, or both. Results showed that most predictors were not reliable when analyzing CFTR missense variants, ratifying the importance of clinical information when asserting the pathogenicity of CFTR missense variants. Our results should contribute to clarify decision making when classifying the pathogenicity of CFTR missense variants.

1 January 2023 in Genetics and Molecular Biology
Verified
Journal Article
Open access
PDF file
FGFlavia Gobetti Gomes
Flavia Gobetti Gomes
Juliano André BoquettJuliano André Boquett
Juliano André Boquett
TKThayne Woycinck Kowalski
Thayne Woycinck Kowalski
JBJoão Matheus Bremm
João Matheus Bremm
MMMarcus Silva Michels
Marcus Silva Michels
LFLucas Rosa Fraga
Lucas Rosa Fraga
Human reproduction goes through many challenges to its success and in many cases it fails. Cases of pregnancy loss are common outcomes for pregnancies, and implantation failures (IF) are common in assisted reproduction attempts. Although several risk factors have already been linked to adverse outcomes in reproduction, many cases remain without a definitive cause. Genetics of female reproduction is a field that may bring some pieces of this puzzle; however, there are no well-defined genes that might be related to the risk for recurrent pregnancy loss (RPL) and IF. Here, we present a literature review of the studies of genetic association in RPL and IF carried out in the Brazilian population and complemented with a database search to explore genes previously related to RPL and IF, where a search for genes previously involved in these conditions was performed in OMIM, HuGE, and CTD databases. Finally, we present the next steps for reproductive genetics investigation, through genomic sequencing analyses and discuss future plans in the study of RPL genetics. The combined strategy of looking for literature and databases is useful to raise hypotheses and to identify underexplored genes related to RPL and IF.

25 May 2021 in Human Fertility
Verified
Journal Article
Closed access
JBJoão Matheus Bremm
João Matheus Bremm
MMMarcus Michels
Marcus Michels
BRBruna Duarte Rengel
Bruna Duarte Rengel
FGFlavia Gobetti Gomes
Flavia Gobetti Gomes
LFLucas Rosa Fraga
Lucas Rosa Fraga
MSMaria Teresa Vieira Sanseverino
Maria Teresa Vieira Sanseverino
Recurrent pregnancy loss (RPL) is one of the most common reproductive failures affecting 1–5% of couples. Smad3 is an effector of signalling of the Transforming Growth Factors-β superfamily (TGF-β), regulating the transcription of several target genes of these cytokines. The objective of this study was to evaluate the influence of a variant on SMAD3 (rs17293443) in RPL. A case-control study was carried out with 149 women who experienced RPL and 159 controls, as well as bioinformatics tools to determine the role of this variant in this condition. Our study showed an allelic (p = 0.023) and genotypic (p < 0.01) association of this variant with the RPL. Our functional in silico predictions suggest that this variant causes a change in SMAD3 expression levels. Alterations in the expression of this gene can directly compromise the Smad3-dependent signalling pathway that is fundamental for key processes for gestation such as steroid hormone regulation and implantation, as demonstrated by ontologies analyses performed and the literature. Our findings regarding the involvement of Smad3 on RPL are a novelty in this field, and they seem to be promising to the clinical management of this condition.